Showing 1 - 4 results of 4 for search 'Timothy Perera', query time: 0.02s
Refine Results
-
1
Cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by <i>MET</i> Inhibition by Concetta D’Ambrosio, Jessica Erriquez, Sonia Capellero, Simona Cignetto, Maria Alvaro, Eric Ciamporcero, Maria Flavia Di Renzo, Timothy Perera, Giorgio Valabrega, Martina Olivero
Published 2022-05-01
Article -
2
OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer by Jonas Steenbrugge, Niels Vander Elst, Kristel Demeyere, Olivier De Wever, Niek N. Sanders, Wim Van Den Broeck, Eric Ciamporcero, Timothy Perera, Evelyne Meyer
Published 2021-03-01
Article -
3
One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer by Jonas Steenbrugge, Julie Bellemans, Niels Vander Elst, Kristel Demeyere, Josephine De Vliegher, Timothy Perera, Olivier De Wever, Wim Van Den Broeck, Ward De Spiegelaere, Niek N. Sanders, Evelyne Meyer
Published 2022-12-01
Article -
4
MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)‐dependent oncogenic driver in vitro and in humanised HGF knock‐in mice by Marie Fernandes, Brynna Hoggard, Philippe Jamme, Sonia Paget, Marie‐José Truong, Valérie Grégoire, Audrey Vinchent, Clotilde Descarpentries, Angela Morabito, Justas Stanislovas, Enoir Farage, Jean‐Pascal Meneboo, Shéhérazade Sebda, Katia Bouchekioua‐Bouzaghou, Marie Nollet, Sarah Humez, Timothy Perera, Paul Fromme, Luca Grumolato, Martin Figeac, Marie‐Christine Copin, David Tulasne, Alexis B. Cortot, Stéphanie Kermorgant, Zoulika Kherrouche
Published 2023-11-01
Article